





















![]()






















CLEANING CHEMISTRIES





INSTRUMENT & SCOPE REPROCESSING CLEANING VERIFICATION











DETERGENT DELIVERY





WHAT WE DO BEST
PROTECTING PATIENTS

SGNA ANNUAL COURSE BOOTH #815
:LWKSURJUHVVLYHWHFKQRORJLHVWKDWVROYHSUREOHPV DQGLPSURYHRXWFRPHV VISIT US AT AORN EXPO BOOTH #219
:LWKH HFWLYHLQVWUXPHQW VFRSHFOHDQLQJVROXWLRQV
HELPING MEDICAL PROFESSIONALS
:LWKDFRPSUHKHQVLYHR HULQJRIXVHUIULHQGO\ HɝFLHQWSURGXFWVWKDWSURPRWHFRPSOLDQFH
DRIVING INNOVATION























April/May 2026


Sourcing & Logistics
8 > From Dashboards to Decisions: Healthcare Supply Chain Transformation Still Lags
DANIEL BEAIRD
12 > Special Report: How Expanding GPO Spend Commitments Hurt Healthcare
JAMES BOUCHARD
Infection Prevention
16 > Promise, Pitfalls, and Protection: Predictive AI in Healthcare
MATT MACKENZIE
Surgical/Critical Care
20 > The HPN Conversation: Balancing Cost Pressures with Clinical Safety
DANIEL BEAIRD
Sterile Processing
24 > Sterile Processing Department of the Year: Nemours Children’s Hospital, Delaware
DANIEL BEAIRD
30 > Endoscopy Certification
ADAM OKADA
32 > From Reference to Routine: Operationalizing AAMI ST79 in Sterile Processing
SARAH CRUZ


April/May 2026, Vol. 50, No. 2
Group Content Director Healthcare
Melinda Taschetta-Millane
mtaschetta-millane@endeavorb2b.com
Editor-in-Chief
Daniel Beaird
dbeaird@endeavorb2b.com
Associate Editor
Matt MacKenzie mmackenzie@endeavorb2b.com
Senior Contributing Editor
Kara Nadeau knadeau@hpnonline.com
ADVERTISING SALES
Director of Sales Healthcare
Jennifer Hazen
jhazen@endeavorb2b.com | 330-598-0308
East & West Coast
Kristen Hoffman khoffman@endeavorb2b.com | 603-891-9122
Midwest & Central
Deborah Baron dbaron@endeavorb2b.com | 917-763-7275
Advertising & Art Production
Production Manager | Ed Bartlett
Art Director | Kelli Mylchreest
Advertising Services
Karen Runion | krunion@endeavorb2b.com
Audience Development
Laura Moulton | lmoulton@endeavorb2b.com
Endeavor Business Media, LLC
CEO Chris Ferrell
COO Patrick Rains
CDO Jacquie Niemiec
CALO Tracy Kane
CMO Amanda Landsaw
EVP Infrastructure & Public Sector Group
Kylie Hirko
VP of Content Strategy, Infrastructure & Public Sector Group
Michelle Kopier
Healthcare Purchasing News USPS Permit 362710, ISSN 1098-3716 print, ISSN 2771-6716 online is published 7 times annually Feb/Mar, Apr/May, Jun/ Jul, Aug/Sep, Oct, Nov/Dec, Nov/Dec IBG, by Endeavor Business Media, LLC. 201 N Main St 5th Floor, Fort Atkinson, WI 53538. Periodicals postage paid at Fort Atkinson, WI, and additional mailing offices. POSTMASTER: Send address changes to Healthcare Purchasing News, PO Box 3257, Northbrook, IL 600653257. SUBSCRIPTIONS: Publisher reserves the right to reject non-qualified subscriptions. Subscription prices: U.S. $164.80 per year; Canada/Mexico $199.56 per year; All other countries $284.54 per year. All subscriptions are payable in U.S. funds. Send subscription inquiries to Healthcare Purchasing News, PO Box 3257, Northbrook, IL 60065-3257. Customer service can be reached toll-free at 877-382-9187 or at HPN@omeda.com for magazine subscription assistance or questions.
Printed in the USA. Copyright 2026 Endeavor Business Media, LLC. All rights reserved. No part of this publication should be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopies, recordings, or any information storage or retrieval system without permission from the publisher. Endeavor Business Media, LLC does not assume and hereby disclaims any liability to any person or company for any loss or damage caused by errors or omissions in the material herein, regardless of whether such errors result from negligence, accident, or any other cause whatsoever. The views and opinions in the articles herein are not to be taken as official expressions of the publishers, unless so stated. The publishers do not warrant either expressly or by implication, the factual accuracy of the articles herein, nor do they so warrant any views or opinions by the authors of said articles.
BY DANIEL BEAIRD
This issue of HPN brings into focus a central tension shaping the future of healthcare operations: the gap between what is possible and what is being achieved.
On one hand, we are proud to recognize Nemours Children’s Hospital, Delaware, as our 2026 Sterile Processing Department of the Year. Their story is not just one of operational excellence, but of intentional design. In an environment defined by workforce shortages and mounting complexity, Nemours has built something rare: a fully staffed, fully certified SPD with zero reliance on contract labor. That didn’t happen by chance. It’s the result of long-term investment in people, structured career pathways, and a deliberate effort to position sterile processing as a clinical discipline, not a backend function.
Equally important is how Nemours connects its work to outcomes. From eliminating flash sterilization to embedding data-driven performance metrics and strengthening OR collaboration, this is a department that has moved beyond tasks to true clinical integration. It offers a glimpse of what high-performing perioperative ecosystems can look like when SPD is treated as a strategic partner.
Across the broader healthcare supply chain, progress continues

but at an incremental pace. Visibility has improved, but decision-making and execution have not kept up. Structural challenges, from GPO dynamics to supplier concentration, continue to limit flexibility and slow innovation.
The same pattern holds true with artificial intelligence as Editor Matt MacKenzie found out. Adoption is accelerating, and the promise is real. But in practice, many systems are still piloting tools that organize data better than they drive action. Integration challenges, workflow misalignment, and trust gaps continue to hold back meaningful impact, particularly in areas like infection prevention where clinical nuance matters.
What ties these threads together is a common theme: healthcare doesn’t lack ideas or technology. It struggles with execution.
That’s why conversations like the one featured in this issue with Dr. Jimmy Chung are so important. The notion that cost and quality are inherently at odds is not just outdated; it’s counterproductive. The real opportunity lies in process discipline, standardization, and aligning clinical and supply chain teams around shared outcomes.
The path forward is becoming clearer. The question is whether the industry is ready to move beyond incremental change and follow the lead of organizations like Nemours.
Jimmy Chung, MD, MBA, FACS, FABQAURP, CMRP, Chief Medical Officer, Advantus Health Partners and Bon Secours Mercy Health, Cincinnati, OH
Joe Colonna, Chief Supply Chain and Project Management Officer, Piedmont Healthcare, Atlanta, GA; Karen Conway, Vice President, Healthcare Value, GHX, Louisville, CO
Dee Donatelli, RN, BSN, MBA, Senior Director Spend symplr and Principal Dee Donatelli Consulting LLC, Austin, TX
J.Hudson Garrett Jr., PhD, FNAP, FSHEA, FIDSA, Adjunct Assistant Professor of Medicine, Infectious Diseases, University of Louisville School of Medicine
Melanie Miller, RN, CVAHP, CNOR, CSPDM, Value Analysis Consultant, Healthcare Value Management Experts Inc. (HVME) Los Angeles, CA
Dennis Orthman, Consulting, Braintree, MA
Janet Pate, Nurse Consultant and Educator, Ruhof Corp.
Richard Perrin, CEO, Active Innovations LLC, Annapolis, MD
Jean Sargent, CMRP, FAHRMM, FCS, Principal, Sargent Healthcare Strategies, Port Charlotte, FL
Richard W. Schule, MBA, BS, FAST, CST, FCS, CRCST, CHMMC, CIS, CHL, AGTS, Senior Director Enterprise Reprocessing, Cleveland Clinic, Cleveland, OH
Barbara Strain, MA, CVAHP, Principal, Barbara Strain Consulting LLC, Charlottesville, VA
Deborah Petretich Templeton, RPh, MHA,Chief Administrative Officer (Ret.), System Support Services, Geisinger Health, Danville, PA
Ray Taurasi, Principal, Healthcare CS Solutions, Washington, DC


Medline Launches Mpower AI-Enabled Supply Chain Solution in U.S. Health Systems
The Mpower platform is built to strengthen supply chain resiliency through real-time AI analytics that help providers anticipate disruptions rather than react to them. By aligning demand forecasts with supply data, the system flags vulnerable items and supports proactive decision-making. It also features an AI-powered chat assistant leveraging Microso Copilot and Azure to streamline user queries and workflow integration.
Read on: hpnonline.com/55360989
Solventum Earns
Diamond Level Resiliency Badge from HIRC
The badge represents the “highest recognition for supply chain strength in healthcare.”
Solventum’s MedSurg segment received the badge as recognition that they “deliver critical healthcare products consistently, even during supply disruptions to help ensure uninterrupted patient care.” The badge is based on a “rigorous, evidence-based assessment of resiliency across key domains, including demand planning, inventory management, logistics visibility, supplier management and risk mitigation.”
Read on: hpnonline.com/55338999
Stryker Cyberattack Disrupts Network, Highlights Healthcare Supply Chain
While Stryker said the disruption primarily affected internal systems, the incident highlights a growing risk for healthcare supply chains. Major manufacturers play a critical upstream role in hospitals’ access to surgical implants, medical devices, and procedural supplies. Cybera acks targeting manufacturers, distributors, and digital ordering platforms could create ripple effects for healthcare providers, particularly as geopolitical tensions spill into cyber activity targeting critical industry infrastructure.
Read on: hpnonline.com/55363423
Medline Invests $150M in Texas to Boost Healthcare Supply Chain Resilience
The project reflects Medline’s broader strategy to scale logistics capacity, improve product availability, and strengthen supply chain resilience for healthcare providers.
Read on: hpnonline.com/55364798

Despite growing interest in AI and new care models, structural inefficiencies and financial strain continue to slow meaningful progress.
BY DANIEL BEAIRD
Healthcare supply chain leaders entered 2026 facing a familiar reality: persistent financial strain, limited structural progress, and growing urgency to modernize operations.
Despite years of discussion around transformation, many of the industry’s core challenges, like technology gaps, supplier concentration, and inefficiencies in procurement, remain largely unresolved. At the same time, new forces are beginning to reshape the landscape, from the cautious adoption of AI to a more measured shift toward ambulatory care.
In a recent conversation, Lars Thording, a longtime healthcare supply chain advisor, shared where the industry is making progress and where it continues to fall short.
While sweeping transformation has yet to materialize, there are early signs of change. One of the most notable is a shift in how health systems approach technology.
“Organizations are becoming more mature in how they think about AI,” Thording said. “Not just as a concept, but as a necessary lever for efficiency and cost
control.” That shift is being driven less by innovation and more by necessity. With margins under sustained pressure, health systems are increasingly viewing technology as essential to long-term financial sustainability and not optional.
There are also early indications of regulatory and legal scrutiny around supplier market dynamics. Recent rulings could help rebalance competition in a space long dominated by a small number of large manufacturers.
At the same time, the anticipated rapid migration to ambulatory surgery centers (ASCs) has been more gradual than expected. Rather than a disruptive shift, the transition has unfolded in a more measured and manageable way, giving health systems time to adapt.
If progress has been incremental, financial challenges have been anything but.
Hospital operating margins hovered
around 1% in 2025 and that leaves little room for error. That fragility has translated into real consequences, including an increase in hospital closures and widespread workforce reductions.
“We’re seeing hospitals make layoffs in the hundreds, sometimes thousands,” Thording noted. “That’s a direct result of sustained financial pressure.”
At the same time, the underlying cost structure continues to worsen. New technologies are driving higher supply costs, while reimbursement rates fail to keep pace. The result is a widening gap that forces health systems into increasingly difficult trade-offs.
Compounding the issue is the industry’s ongoing inability to effectively aggregate demand. Despite decades of reliance on group purchasing organizations (GPOs), many providers still lack the leverage needed to counterbalance large suppliers.
A deeper partnership is reshaping how health systems manage cost, efficiency, and long-term sustainability.
The pandemic reshaped nearly every aspect of healthcare, but few relationships have evolved more significantly than that between finance and supply chain. As health systems face ongoing margin pressure, CFOs are taking a more active role in sourcing strategy, operational efficiency and non-clinical spend management.
In this Q&A, David Kirshner, a former health system CFO and now managing partner of healthcare at LogicSource, shares how that relationship is changing, and what it means for the future of healthcare supply chain.
How has the relationship between CFOs and supply chain leaders evolved since the pandemic?
Kirshner: The last four to five years have changed everything. Historically, CFOs focused on revenue, volume, margin and the top line of the P&L, while supply chain was more transactional and heavily tied to clinical purchasing through GPOs. During the pandemic, we experienced dramatic swings in volume, workforce disruptions, and growing financial pressure as temporary funding began to fade. That forced CFOs to rethink how the organization operates, not just how it generates revenue.
As a result, there’s been a much deeper focus on cost structure, and supply chain has become a more strategic function. CFOs are now asking: Where are the opportunities we’ve overlooked?
What role does purchased services or non-clinical spend play in that shi ?
Kirshner: It’s huge and o en underappreciated. Non-clinical spend typically represents about 20% to 22% of a health system’s net patient revenue. That includes design and contruction, facilities, information technology, human resources, corporate services and more.
Historically, healthcare supply chain teams were intensely focused on clinical sourcing and supplier management. Non-clinical spending was an a erthought and did not receive the
Rethinking the GPO Model
That reality is fueling growing skepticism around the traditional GPO model.
Originally designed to pool purchasing power and improve pricing, GPOs have struggled to consistently deliver on that promise in today’s environment. Prices continue to steadily rise, and many supply chain leaders
same talent, resources nor investment in those areas unless leadership made it a priority. But that’s changing.
If you’re serious about margin improvement, you can’t ignore the non-clinical capital expenditures and operating expenses. It’s simply too significant.
What does effective collaboration between finance and supply chain look like today?
Kirshner: It’s no longer optional; it’s essential. And it’s not just about finance and supply chain. IT, design and construction must be part of the equation as well.
The most successful organizations are operating as integrated teams. CFOs, CIOs, facilities executives and supply chain leaders are working together in a much more connected, workflow-driven environment.

David Kirshner
Relationship skills are just as important as technical expertise. You need trust, alignment, and a willingness to collaborate across disciplines.
One of my former colleagues used to say, “If your goals start with ‘in collaboration with,’ you’re on the right track.” That mindset is critical today.
Where are health systems finding new efficiency opportunities?
Kirshner: Efficiency today goes far beyond price negotiation.
Take space utilization. At my former health system, we started treating departments more like tenants and holding them accountable for how they used space. When you look at whether a room is 40% utilized versus 80%, that’s a major opportunity. Energy is another big one. Some health systems are spending $50 million or more annually on utilities. CFOs can’t just pay those bills anymore. They need to think strategically about energy usage, efficiency, and even alternative sources. It’s really about asset optimization and ge ing the most value out of what you already have.
How is the role of supply chain expanding in nonclinical areas?
Kirshner: We’re seeing a much broader mandate for supply chain’s involvement, especially in areas like IT, facilities and corporate services.
At LogicSource, we bring in expertise from other industries like retail, consumer goods, and beyond to help health systems manage these categories more effectively.
increasingly question whether these organizations are effectively shifting negotiating power.
“The value proposition hasn’t fully materialized,” Thording said. “Hospitals are still facing rising costs and limited flexibility.”
Adding complexity is the financial relationship between health systems and GPOs. Many organizations receive
Health systems recognize they can’t build deep expertise in every area internally. So, they’re looking for partners who can bring that knowledge and apply it in a healthcare context.
What can healthcare learn from other industries?
Kirshner: A lot. Health systems tend to think of themselves as a single entity, but they’re really a collection of different businesses, including real estate, hospitality, retail, research, and more.
On the clinical side, there’s a high level of regulation, which is appropriate. But sometimes that mindset carries over into non-clinical areas where it isn’t necessary.
That can lead to what I call “wedding pricing” or paying more than you should for services that could be managed more efficiently using practices from other industries.
Looking outside healthcare gives you a valuable reference point.
How are large health systems responding to this approach?
Kirshner: We’ve seen strong interest from major systems like Stanford Health Care, SSM Health, WellSpan Health, Ochsner Health, Su er Health, and Allina Health.
Many of these organizations are highly sophisticated, but they recognize there are still gaps, especially in specialized areas.
As health systems continue to consolidate, standardization becomes critical. When you bring together multiple hospitals, you inherit a lot of variation in processes and vendors. Standardizing those elements simplifies operations and reduces cost.
What does this mean for the future role of the healthcare CFO?
Kirshner: The role is much more operational than it used to be.
CFOs are now deeply involved in how the organization runs, from supply chain and IT to facilities and energy management. There’s a growing overlap between finance and operations.
And with the financial pressures ahead, that’s only going to intensify.
We’re looking at a challenging environment over the next few years. Health systems need to find new ways to operate more efficiently, and supply chain will play a central role in that.
What should health system leaders be thinking about right now?
Kirshner: They need to broaden their perspective.
Supply chain isn’t just about clinical products or negotiating price. It’s about managing a significant portion of the organization’s cost structure in a smarter, more integrated way.
The systems that embrace that, and truly align finance, supply chain, and IT, are going to be in a much stronger position moving forward.
payments tied to participation, creating a dependency that can discourage alternative sourcing strategies, even when performance falls short.
The result is a model that, in some cases, reinforces the status quo rather than enabling transformation.
Against this backdrop, AI has emerged as one of the most discussed, and misunderstood, opportunities in healthcare supply chain.
According to Thording, the key to success lies in shifting the starting point.
“Too many organizations begin with the technology,” he said. “It should start with identifying inefficiencies and then applying the right tools to solve them.”
There is no shortage of potential use cases. Demand forecasting, inventory optimization, warehouse automation, supplier risk management, and compliance tracking all represent areas where healthcare lags other industries.
However, one of the biggest risks is over-indexing on visibility without enabling action.
“Supply chain leaders don’t need more dashboards,” Thording said. “They need decision support and execution.”
In other words, the next phase of AI adoption must move beyond reporting and toward operational impact.
Part of the challenge is that healthcare continues to trail other sectors in supply chain sophistication.
Companies like Amazon have spent decades refining logistics, forecasting, and inventory management capabilities that healthcare is only beginning to explore.
“There’s a significant gap—easily a decade or more,” Thording said.
Closing that gap will require more than internal investment. It will demand greater willingness to learn from, and collaborate with, other industries that have already solved many of these challenges.
While technology offers a path forward, structural market dynamics remain a major constraint.
Large medtech manufacturers continue to hold significant negotiating leverage, often leaving individual health systems with limited ability to influence pricing or terms. In some cases, bundled agreements further restrict choice, tying purchasing decisions to broader supplier relationships.
“The power imbalance is still very much in place,” Thording said.
That imbalance also has implications for innovation. Smaller suppliers face significant barriers to entry. With large distributors controlling the majority of hospital spend, many never gain meaningful access to the market.
“In reality, a small supplier often only becomes relevant once it’s acquired by a larger company,” Thording said.
The result is a system that can stifle competition and slow the pace of innovation.
Despite these challenges, there are clear areas of opportunity.
AI, when deployed strategically, has the potential to unlock significant efficiency gains across the supply chain. At the same time, the continued growth of ambulatory care presents a chance to rethink how and where care is delivered.
While technology offers a path forward, structural market dynamics remain a major constraint.
While hospitals often view ASCs as a threat to revenue, they also represent an opportunity to build more flexible, costeffective care models.
“The organizations that embrace both technology transformation and care model evolution will be best positioned going forward,” Thording said.
Healthcare supply chain is at an inflection point. Financial pressures are forcing action, but structural barriers continue to slow progress.
The path forward will require more than incremental change. It will demand a rethinking of long-standing models, from GPO relationships to supplier dynamics, and a more disciplined approach to technology adoption.
For health systems, the stakes are clear: those that move from insight to execution will be best equipped to navigate the challenges ahead. HPN
Mandatory spend quotas are limiting supplier choice and shi ing procurement risk onto health systems.
BY JAMES BOUCHARD
Group purchasing organizations (GPOs) have played a meaningful role in healthcare supply chains for decades. The original idea was simple: bring hospitals together, leverage collective scale, reduce costs, and simplify purchasing. At their best, GPOs
were partners advocating on behalf of health systems.
That’s no longer the reality for many healthcare providers.
Today, health systems are increasingly locked into GPO agreements that require the majority of their spend to flow through a single portfolio. Miss
a compliance threshold or spend target, and penalties follow. These contracts don’t just influence purchasing behavior; they dictate it and influence bad behavior.
The result is a model that shifts risk onto the health system, limits supplier choice, and, in some cases, drives decisions that serve GPO economics better than clinical, operational, or patient needs.
There is a better way to think about procurement. And health systems have more leverage than they’re often led to believe.
Originally, GPOs existed to aggregate demand and negotiate favorable pricing, particularly in high-volume, standardized categories like medicalsurgical supplies. Products such as exam gloves, syringes, and basic consumables are largely interchangeable, making them ideal for aggregation and national contracting. Participation was largely voluntary. Health systems could opt out when a contract didn’t make clinical, operational, or strategic sense.
Over time, several forces reshaped that model:
• Fewer, larger organizations now control a disproportionate share of healthcare spend.
• GPOs rely heavily on administrative fees paid by suppliers, creating a built-in tension between driving supplier volume and optimizing provider outcomes. In simple terms, lower prices don’t always align with GPO economics.
• As provider margins tightened, GPOs increasingly positioned “compliance” as a substitute for strategy, a way to create savings certainty without addressing fit or performance.
• Once traditional categories like medical supplies and PPI were largely locked in, GPOs pushed





































Clinical Intelligence for the Healthcare Ecosystem














Sourcing + Logistics
Sterile Processing
Surgical + Critical Care
Infection Prevention
Continuing Education


aggressively into purchased services. Products like IV solutions are essentially the same from one hospital to the next, making them easy to standardize at scale. Services such as snow removal, HVAC maintenance, or IT staff augmentation are not. They depend on local labor markets, facility complexity, and site-specific service expectations – factors the GPO model was never built to manage effectively.
The result is a landscape defined by mandatory spend commitments, minimum compliance thresholds, and clawback provisions that penalize health systems for exercising judgment.
Modern GPO contracts commonly require health systems to:
•Route 80–90% or more of eligible spend through the GPO.
•Maintain category-level compliance.
• Pay penalties, fees, or rebate claw-backs if targets are missed.
•Extend participation into purchased services and indirect spend, where standardized national contracts often break down.
These provisions are typically framed as “alignment incentives.” In practice, they function more like financial handcuffs. The downstream effects are real and predictable.
GPOs prioritize volume with preferred suppliers, not necessarily the best fit. Health systems are often forced to use vendors that are clinically suboptimal, operationally inconsistent, and poorly suited to specific geographies or care settings. New entrants, regional providers, and differentiated solutions struggle to gain traction because shifting spend threatens compliance. In purchased services, national vendors are favored even when service quality varies widely by location.
when applied to purchased services? In categories driven by local markets, custom scopes, and variable service levels, the idea that a nationally set GPO price represents true market value becomes even harder to justify.
The issue isn’t awareness; it’s constraint. When volume commitments must be protected, the freedom to negotiate aggressively or move to a better-fit supplier largely disappears.
When purchasing decisions are driven by contractual obligation instead of clinical and operational fit, care suffers.

Across health systems, the patterns repeat:
• Clinicians and department leaders are constrained from using preferred suppliers.
• Supply disruptions are tolerated because switching vendors triggers penalties.
Rather than being accountable for contract performance, GPOs shift risk to the health system. Providers pay for “non-compliance” even when decisions are driven by valid clinical or operational needs. Sourcing decisions become about hitting a number, not delivering outcomes.
There’s a long-standing saying in healthcare procurement that the GPO price is just the starting point, even in highly standardized, high-volume med/surg categories. Most leaders understand that GPO pricing is often not truly competitive.
That reality begs an important question: if the GPO price is only a starting point for supplies that are easy to aggregate, how non-competitive is that same starting point
•Forced standardization where variation is clinically appropriate.
• “Savings” achieved on paper but offset by labor, utilization, or outcome impacts.
•Purchased services are locked into preferred vendors that limit access to local expertise or flexible service models.
In an environment focused on value-based care, these tradeoffs aren’t just inefficient -- they’re counterproductive.
Despite the risks, many organizations continue to enter aggressive spend-commitment agreements. Common
reasons include the appeal of simplicity, short-term financial pressure, and limited internal sourcing capabilities.
Too often, the long-term cost of lost flexibility is underestimated, or there’s no independent expertise available to challenge GPO assumptions during negotiations.
The good news is this: these arrangements are a matter of choice. Health systems have more leverage than they realize, especially when they rethink both the strengths and weaknesses of GPOs.
Minimum spend commitments should never be treated as standard. Health systems should require category-level opt-outs, particularly for purchased services, eliminate penalties tied solely to volume, and tie incentives to performance, not compliance.
Aggregation is not strategy, and it’s not appropriate for every category. Leading organizations use strategic sourcing to evaluate markets, especially in services, and leverage GPOs selectively where the value proposition is clear. Providers should fully understand supplier administrative fee structures, share-back thresholds and tiers, and where GPO incentives may diverge from provider outcomes.
Contracts must explicitly preserve physician-led decision-making, product trials and innovation pilots, and local sourcing where it makes sense. Every agreement should include reasonable termination rights, categorylevel disengagement options, and protection against retroactive penalties.
Procurement must serve the health system, not the other way around. Working across complex healthcare environments consistently shows that:
• True savings in purchased services come from competition, expertise, and strategy, not aggregation.
• Flexibility produces better outcomes than forced compliance.
• Strategic sourcing outperforms the GPO model, delivering average savings of more than 10% versus GPO pricing in clinical and non-clinical services.
Health systems don’t need to choose between savings and autonomy. With the right approach, they can, and should, have both. Healthcare is too complex, too critical, and too human to be governed by rigid spend quotas and punitive contracts. The future demands procurement models that are smarter, more transparent, and more accountable. Models that empower providers instead of restricting them. HPN




As predictive AI takes center stage in health systems, the need for human oversight remains essential.
BY MATT MACKENZIE
Predictive artificial intelligence (AI) and machine learning (ML) are increasingly being used in healthcare settings across the care spectrum. A systematic review of studies examining these systems in healthcare serves as a kind of quantification. A brief summary of how often predictive machine learning, for instance, has been applied in “various healthcare domains such as ICU (sepsis, mortality), oncology, cardiology, diabetes management, and COVID-19.”1

New tools are seemingly being introduced or developed on a daily basis. We’ve written about a number of them on our website; in March 2026 alone, for instance, a study funded by the National Institutes of Health included the development of a machine learning model to assess CT scans, successfully categorizing scans between two codes over 81% of the time. It was also able to identify which patients were at higher risk of developing chronic diseases five years in advance around 75% of the time.2
Additionally, physicians are using artificial intelligence more frequently, according to survey results from the American Medical Association (AMA). Adoption rates of digital health and AI “soared from 38% to 66% over the last year,” and a majority of physicians see an advantage to using AI in their practices.3 The question becomes how transparency is maintained throughout the development process so that physicians feel comfortable using
the tools at their disposal. A number of frameworks have been published by various organizations and in various journals to that effect, attempting to establish footing in an ever-shifting and still-forming industry as the technology advances rapidly.
There are serious questions surrounding how much of a miracle cure this technology actually represents. The temptation to integrate it everywhere with the hope that it will seamlessly reduce physician burnout to misdiagnoses is a strong one, but the reality of where the various projects are needs to be taken into account.
To cut through the noise on where things stand today and where they could end up, we spoke to Kelly Holmes, MS, AL-CIP, FAPIC, Senior Associate, Infection Prevention & Management Associates, Inc. (IP&MA).
Where is predictive surveillance making the biggest measurable impact in infection prevention today?
Holmes: When people talk about AI in infection prevention, they’re usually referring to three areas: predictive models that estimate risk, tools that help detect infections earlier, and decision-support tools that help infection preventionists review charts or apply surveillance definitions. Most predictive models for HAIs are still being studied or piloted rather than used routinely. What we’re seeing right now is more interest in surveillance platforms that help infection preventionists identify potential cases by pulling together structured surveillance data from the medical record.
What specific infection types or risk scenarios are most “AI-ready” right now?
Holmes: In the research literature, infections like C. difficile, surgical site infections, and CLABSIs show up frequently in modeling studies. Those tend to work better because there are clearer risk factors and structured data available in the electronic health record. Infections that rely heavily on interpreting clinical correlation or narrative documentation are much harder to model.

What’s the biggest misconception healthcare leaders have about AI in infection prevention?
Holmes: One of the biggest misconceptions is that predictive surveillance for infections is already widely implemented in hospitals. In reality, most infection prevention programs still rely heavily on retrospective surveillance and manual chart review. The technology is exciting and evolving quickly, but integrating it into real infection prevention workflows is still very
much in progress. Developing predictive models is only the first step. The bigger challenge is integrating those models into infection prevention workflows in a way that clinicians trust and can actually utilize.
How early can today’s models realistically flag risk compared to traditional surveillance?
Holmes: Across many studies, you tend to see similar variables come up, like device exposure, antibiotic use, severity of illness, comorbidities, and length of stay. Laboratory results and microbiology data also play an important role. That said, the predictive strength of these factors can vary a lot across hospitals, which is why local validation is so important.
What’s the difference between a clinically useful alert and a statistically impressive one?
Holmes: A model can perform very well statistically and still not be useful in practice. If an alert fires too often or doesn’t lead to a clear action, clinicians will start ignoring it. A clinically useful alert has to fit into the workflow and provide information that helps someone make a decision.
What are the biggest integration barriers between lab systems, EHR data, and environmental inputs?
Holmes: One of the biggest challenges is simply bringing all the relevant data together. Infection prevention surveillance often requires pulling information from multiple places in the electronic health record, including (but not limited to) microbiology, imaging, device documentation, procedure codes, and patient movement data. Some of that information is structured, like lab results or device days, but a lot of it is buried in clinical notes that infection preventionists have to review manually. Even within the same EHR platform, workflows and modules can vary across hospital systems, which means tools developed in one environment may not translate easily to another. Data interoperability and workflow variation remain major barriers to implementing predictive tools at scale.
How mature are health systems in pulling these data streams together?
Holmes: Some large academic medical centers with strong informatics teams are starting to pilot these types of systems. But many hospitals, especially smaller or rural facilities, don’t yet have the infrastructure or data science resources to support advanced predictive analytics. That creates a real concern about an equity gap as these technologies evolve.
How do you ensure data integrity before feeding it into predictive models?
Holmes: Before feeding data into predictive models, organizations first need secure data environments and governance processes to protect patient information. After that, the focus shifts to data quality, making sure variables are consistently defined and documented across systems. Infection prevention data can be particularly complex because surveillance often combines structured data with information buried in clinical notes. That’s why clinical validation and ongoing monitoring are essential before models are used operationally.
How much time are modern AI systems saving IP teams on chart review?
Holmes: There’s a lot of interest in using AI to reduce the amount of manual chart review required for surveillance, but the evidence on time savings is still limited. Many health systems now have surveillance dashboards that organize information from multiple parts of the medical
“Infection prevention surveillance o en requires interpreting clinical documentation and determining whether cases meet specific reporting definitions.”
KELLY HOLMES, SENIOR ASSOCIATE, INFECTION PREVENTION & MANAGEMENT ASSOCIATES, INC. (IP&MA).
record, such as microbiology results, device documentation, vitals, and flowsheet elements, which can help infection preventionists identify potential cases more quickly.
These tools can save time by making the relevant information easier to find, but they’re not perfect. Algorithms may miss some cases because of the nuances of surveillance definitions, which is why many programs still validate cultures or other key data sources as part of their workflow. Some organizations are also beginning to experiment with enterprise AI tools that help infection preventionists summarize data or generate visualizations for reports and meetings. Tools like that can ultimately free up time for IPs to spend more time on the units working directly with clinical teams.
Holmes: Infection prevention surveillance often requires interpreting clinical documentation and determining whether cases meet specific reporting definitions. Signs and symptoms may appear in different parts of the record,
and IPs need to review the clinical context to determine whether criteria are met. That kind of judgment is difficult to fully automate, so human review remains a critical part of the process.
Does automation improve surveillance accuracy, or just efficiency?
Holmes: Most current systems automate data gathering rather than the surveillance decision itself. Automation can definitely improve efficiency by helping IPs locate relevant data more quickly. Many systems now provide dashboards that pull together structured data like lab results or device exposure, which can be a helpful starting point for surveillance. But infection preventionists still need to review clinical notes, flowsheets, imaging, and various other parts of the medical record to determine whether a case actually meets surveillance definitions.
What governance structure is required before deploying predictive tools?
Holmes: Successful implementation usually requires collaboration between infection prevention teams, clinical leadership, and clinical informatics or IT teams who understand the data infrastructure. Organizations also need clear governance around data security, model validation, and how alerts will fit into clinical workflows.
How important is frontline clinical buy-in?
Holmes: Frontline buy-in is essential. Infection prevention work depends heavily on collaboration with nurses, physicians, and unit leaders, and any tool that adds alerts or changes workflow needs to make sense to the people using it.
What metrics should organizations track to determine whether AI is working?
Holmes: Organizations should look at both operational and quality metrics. For infection prevention teams, that might include things like time spent on chart review, how consistently true cases are identified or missed, and whether alerts lead to meaningful prevention actions. It’s also important to track whether the tool is actually being used and whether it supports existing prevention workflows. The real measure of success is whether the tool helps teams turn data into prevention at the bedside.
What problems in infection prevention does AI NOT solve well today?
Holmes: AI is really starting to help infection prevention teams with things like quickly generating data
visualizations, summarizing information for reports, creating educational materials, and supporting surveillance by pulling together structured data such as microbiology results and device tracking. But it is not widely predicting infections or automatically determining whether cases meet surveillance definitions. Infection prevention surveillance still requires clinical interpretation.
Some tools may also help identify patients who appear to be at higher risk earlier in their hospitalization. But identifying risk is only part of the equation. Ultimately, the clinical team has to act on that information. Infection prevention programs already share data about device use and other risk factors, and translating those insights into changes in clinical practice can be challenging. Technology can help surface the risk, but the prevention work still depends on how that information is used at the bedside.
Where is the hype most disconnected from operational reality?
Holmes: A lot of hype assumes that predictive surveillance for infections is already widely implemented in hospitals. In reality, most IP programs still rely heavily on retrospective surveillance and manual review of the electronic chart.
What will likely be possible in 3–5 years that isn’t yet viable?
Holmes: In the next several years, we will likely see more tools that help infection preventionists interpret large amounts of clinical data more efficiently. We could see changes in surveillance definitions that align with more structured criteria that can be extracted directly from the EHR. Advances in natural language processing will likely make it easier to review clinical notes and other unstructured elements of the chart to identify relevant information for surveillance.
We’ll probably also see more predictive models being tested and integrated into existing clinical platforms as vendors work to embed these capabilities within electronic health records and surveillance systems. At the same time, health systems are likely to invest more in AI governance and implementation frameworks to ensure these tools are validated, used safely, and integrated effectively into clinical workflows. HPN
REFERENCES:
1. Al-Nafjan, Abeer, et al. “Artificial Intelligence in Predictive Healthcare: A Systematic Review.” J Clin. Med. https://pmc.ncbi.nlm.nih.gov/articles/PMC12525484/
2. MacKenzie, Matt. “NIH-Funded Researchers Develop AI Model to Assess CT Scans.” Healthcare Purchasing News. https://www.hpnonline.com/healthcare-it/news/55362081/nih-fundedresearchers-develop-ai-model-to-assess-ct-scans
3. Lubell, Jennifer. “Why doctors should be at the heart of AI clinical workflows.” AMA. https:// www.ama-assn.org/practice-management/digital-health/why-doctors-should-be-heart-aiclinical-workflows
Daniel Beaird, Editor-in-Chief, Healthcare Purchasing News, in conversation with Dr. Jimmy Chung, a board-certified surgeon and clinical transformation leader.
BY DANIEL BEAIRD
Daniel Beaird, Editor-in-Chief, HPN: Healthcare leaders are under increasing pressure to reduce costs without compromising patient or caregiver safety. This discussion focuses on how organizations can strengthen infection prevention and safety efforts while also acting as responsible financial stewards, particularly in areas such as PPE, sharps disposal, and container solutions.
Dr. Jimmy Chung joined me for this conversation.
A board-certified surgeon and clinical transformation leader, Dr. Chung brings more than 25 years of experience across patient care, physician leadership, and supply chain strategy.
To start, I asked whether cost containment and clinical safety are truly in tension—or whether that framing is misleading.
Dr. Jimmy Chung: It is somewhat of a false narrative. There is a common assumption that lowering costs leads to lower quality, or that improving quality and safety must increase costs. In practice, that is not usually what the data shows.
If you study health systems closely and compare quality outcomes with the cost of care, you often find that the highest-quality care is associated with lower costs. I cannot say one necessarily causes the other, but the correlation is real. At nearly every level, from national data
down to individual clinicians, organizations can reduce costs and improve quality at the same time.
The tension leaders feel between cost and safety is usually not inherent to the products or the safety goals themselves. More often, it comes from misalignment in how organizations pursue those goals and from the difficulty of managing change.
Where do organizations most often get this wrong?
They tend to focus too heavily on products and technology, and not enough on process.
Hospitals measure a wide range of safety metrics— hospital-acquired conditions, surgical site infections, falls, ulcers, line-associated infections, and caregiver safety indicators. They also invest in solutions intended to improve those outcomes. But what often gets overlooked is the process behind the problem.
A good analogy is driving a gas guzzler and deciding the answer is to carry extra gas cans in the car. What you really need is a more efficient vehicle. In the same way, many safety issues are not caused by a lack of products or technology. They are rooted in communication gaps, flawed processes, and poor change management.
Value-based care is discussed constantly in healthcare. How should leaders think about value today?
I do not think value needs to be redefined so much as refocused.
The value equation is still straightforward: quality and outcomes over cost. Quality is the experience of care delivery. Outcomes are whether you achieved the intended clinical result. Cost ranges from the price of a product to the broader cost of care.
What matters is that hospitals think about value as it is experienced by both the patient and the caregiver, not just as a purchasing exercise or a one-time transaction.
What happens when safety products are treated as commodities rather than clinical tools?
We tend to use the word commodity as if it is negative, but that is not necessarily true.
A high-quality clinical tool that protects patients and caregivers can be standardized and used reliably across settings. In that sense, quality itself can be commoditized. If organizations have the right standard operating procedures and use data to guide decisions, the specific product often matters less than people assume.
We saw that during COVID, and we had already seen it in many categories before then. In many product
lines—including some physician preference items—there is far more opportunity for standardization than many organizations realize.
Beaird: As we shift to PPE, what should healthcare leaders be thinking about now that the crisis phase of the pandemic has passed?
Dr. Chung: One of the biggest lessons from the pandemic was that we lacked both data and education.
In many ways, we created our own shortages because we did not know clearly who should use which PPE, under what circumstances, and at what level. As a result, we made some flawed assumptions—one of them being that everyone needed the highest level of PPE.
The value equation is still straightforward: quality and outcomes over cost.
We also overestimated how much filtration efficiency alone determines what makes PPE “best.” At the submicron level, masks and filters do not simply act like sieves. The science is more complex than that. With better understanding and better data, we could have matched the right PPE to the right worker and the right care setting much more effectively.
The goal now should be preparation. Organizations should define in advance who needs what type of PPE, under what conditions, and what inventory levels are actually required so they do not repeat the panic purchasing of the pandemic era.
What role does clinician engagement play in PPE conversions and standardization?
Clinical stakeholders have to be part of the conversation, but that does not mean every decision becomes democratic. Leadership still has to lead.
For PPE conversion and standardization, there should be a clear clinical lead—whether that is infection prevention, surgical services, or another department. The important thing is that the right clinicians are involved, everyone is reviewing the same data, and decisions are made from the same playbook.
One of the mistakes organizations make is simply asking doctors or nurses what they want and then purchasing accordingly. That is not always the right approach. During COVID, some specialties had disproportionate influence on PPE discussions, while others with equally valid concerns were underrepresented.
The better approach is to ensure balanced representation, listen carefully, and then make decisions using evidence rather than anecdote or volume of opinion.
Sharps disposal and containers do not always get the same attention as PPE, but they are foundational to infection prevention and point-ofcare safety
How should organizations think about total cost of ownership for PPE, sharps, and related safety products?
Dr. Chung: This is where safety strategy intersects with sustainability.
For single-use products, the cost is not just the purchase price. You pay for the item when you buy it, and then you pay again when you dispose of it. There is also the cost of inventory, which is not always well understood.
In the case of sharps, some costs are easier to see. A needlestick injury typically triggers reporting, employee health involvement, lost time, and reduced productivity. Those are measurable events. PPE is
more difficult because the cost of a failure or breach is harder to define and quantify.
Still, when leaders talk about total cost of ownership, they need to look beyond the product itself and examine the cost of the entire program, including waste, inventory, labor, and safety events.
What do leaders often overlook there?

in busy clinical environments. Sharps safety products are designed to interrupt those shortcuts, but they cannot solve the problem on their own. If organizations want fewer injuries, they need more than a different container design. They need a culture of safety and a process that discourages workarounds.
Dr. Chung: They overlook that sharps safety is primarily a process issue, not a product issue.
A sharps container is often treated as just a waste bin, but the real risk lies in how people use it. Any product can contribute to safety issues if protocols are not followed. People naturally look for shortcuts, especially
What helps hospitals avoid disruption during portfolio simplification or vendor consolidation?
Dr. Chung: Vendor support matters greatly.
If a health system is reducing SKUs, narrowing vendors, or converting from one product to another, both the incoming and outgoing vendors should






















support the transition. That includes helping with availability, stock burndown, restocking, and staff support.
A vendor relationship should not end simply because a contract does. Hospitals may work with that supplier again in the future. Good transitions depend on continuity, professionalism, and mutual support.
How should healthcare leaders think about resilience in safety products and critical supply categories?
Dr. Chung: Resilience is not unique to PPE or safety products. It applies to all critical products.
Organizations have to balance “just in time” and “just in case.” Resilience does not mean overstocking everything. It means having the right amount of inventory, understanding your suppliers’ capabilities, and having clear expectations for how they will support customers during disruptions.
The same lessons keep resurfacing—whether the issue is PPE, IV fluids, contrast media, tubing, or something else. Resilience planning needs to be broader than any single category.
When does a product conversion make sense?
Dr. Chung: A conversion makes sense when an organization has clearly defined the problem it is trying to solve.
If a root cause analysis shows that a process is leading to errors, leaders can ask whether a product is creating a barrier to safety or whether another tool might reduce the opportunity for human error. But the trigger should be a clearly identified problem—not a vendor pitch.
Organizations should not convert simply because a supplier claims a product will reduce injuries or improve outcomes. They need to establish what they are solving for
and what metric they will use afterward to determine whether the conversion actually worked.
Can product design still help reduce exposure risk?
Dr. Chung: Yes, but only within the right process.
Ideally, a sharps container should make safe disposal easy. It should not introduce extra barriers that tempt people to improvise. At the same time, it cannot be so open or oversized that it invites misuse or waste.
In practice, though, even the best design does not eliminate the need for clinician education and protocol. The central issue is still whether staff know how to manage sharps safely and consistently.
What role does domestic manufacturing play in that conversation?
Dr. Chung: Domestic manufacturing can reduce exposure to geopolitical risk and shorten supply chain logistics, which may improve reliability and trust. But it is not a complete safeguard.
Even domestic manufacturers may rely on offshore raw materials or components. So while it is valuable for hospitals to have relationships with domestic manufacturers, those manufacturers also need to be transparent about their own upstream vulnerabilities.
One of the more striking points you raised was that hospitals may not fully learn from past mistakes.
Dr. Chung: I think that is the reality. Human beings—and the systems we build—tend to repeat the same behaviors under stress.
The next major disruption will likely trigger some of the same instincts we saw during COVID, especially panic buying. That is not just a supply chain problem; it is a human
behavior problem. So perhaps one of the most important lessons is to recognize that these behaviors will likely happen again and to plan around them rather than assume they will not.
If there is one area hospitals often overlook as a practical opportunity, what is it?
Dr. Chung: Waste reduction.
There is a tremendous amount of waste in healthcare, particularly in PPE. We often assume that single-use automatically means safer use, but that assumption has not always been fully validated. There may be opportunities to reduce waste, reuse appropriate materials more effectively, and build programs around recycling.
Waste is not only an environmental issue. It is also a financial issue. Hospitals can make meaningful gains by being more intentional about how products are used, discarded, and managed.
Finally, how can physician leadership help accelerate meaningful change in supply chain?
Dr. Chung: Hospitals are increasingly interested in bringing physician leadership into supply chain, and I think that is a positive development.
The exact structure may vary— medical director roles, part-time leadership, full-time integration—but the appetite is there. At the same time, physicians who step into these roles need to do so with humility. Supply chain leadership is not about walking in and declaring that you have the answer. It is about collaboration, teamwork, and a willingness to learn.
Physicians can bring important clinical insight to supply chain decisions, especially when it comes to interpreting evidence, evaluating outcomes, and helping integrate clinical and operational priorities. I think supply chain teams are actively looking for those partnerships. HPN

BY DANIEL BEAIRD
At a time when staffing shortages continue to challenge sterile processing departments nationwide, Nemours Children’s Hospital, Delaware, has quietly built something rare: a fully staffed, fully certified, high-performing SPD operating at scale without reliance on travelers.
Supporting 12 operating rooms, procedural suites, and 13 clinics across 18 specialties, the department processed instrumentation for more than 12,000 pediatric patients in 2025 while maintaining a 0% vacancy rate and 100% CRCST certification across its team.
But the real story isn’t just performance; it’s how Nemours got there.
While many organizations continue to react to workforce shortages, Nemours took a different approach: build a sustainable talent pipeline from the ground up.
The department has embedded workforce development into its operational strategy, partnering with Delaware Technical Community College and local training programs to create structured pathways into the profession.
Students receive hands-on clinical experience through externships and up to 400 hours of on-site training, allowing the organization to identify and develop talent early.
That strategy is now expanding further. In 2026, Nemours joined the Health Anchor Network (HAN) WorkAdvance initiative, a workforce development model that combines employer-based training, community recruitment, and guaranteed career pathways.
The result: a competitive applicant pool, strong retention, and a workforce that is not only stable, but continuously advancing.
Nemours has also redefined expectations for what it means to be an SPD professional.
Certification is not optional; it’s foundational. CRCST certification is required for employment, and the department is actively moving toward making CER certification a standard as well. Financial incentives, continuing education, and structured advancement pathways reinforce that expectation.
A four-level clinical ladder ties certification directly to career progression and compensation, while top performers achieving “Gold Crown” status (four certifications) are recognized in formal ceremonies alongside surgical staff.
“We actively support certification, conference attendance, and an SPD-specific clinical ladder, reinforcing that sterile processing is a profession, not just a job,” said Edna Gilliam, Assistant Vice President of Perioperative services & SPD for Nemours.
This level of professionalization does more than improve technical competency. It elevates the role of SPD within the broader perioperative ecosystem.
Nemours’ investment in technology goes beyond routine upgrades and reflects a deliberate strategy to improve resilience, efficiency, and quality.
The department was the first in the U.S. to implement a self-contained steam-generation autoclave, eliminating reliance on centralized utilities while reducing energy consumption and environmental impact.
It also led early adoption of advanced cleaning technologies, including a Safe Cleanbox system capable of reaching microscopic crevices in complex instruments, addressing one of the most persistent challenges in sterile processing.
Even frontline workflows reflect innovation. Techniciandriven improvements, such as customized lighted inspection tables to detect defects in sterile wrap, demonstrate how operational excellence is being shaped from within.
In one of its most significant practice changes, Nemours eliminated flash sterilization entirely more than five years ago.
By removing autoclaves from operating room sterile cores and standardizing reprocessing within SPD, the organization aligned fully with best practices while reducing variability and risk.
The transition required deep collaboration between surgeons, OR staff, and SPD, but the payoff was substantial: improved standardization, enhanced compliance, and more predictable instrument availability.
One of Nemours’ most meaningful transformations has been cultural, turning a once-strained relationship between SPD and the operating room into a tightly aligned, highfunctioning partnership.
When SPD leadership came under unified oversight, the organization made a deliberate shift toward a “one team” mindset, breaking down silos that had historically created tension between departments.
Structural alignment played a key role. Nemours introduced mirrored leadership roles, pairing lead SPD technicians with OR leads by specialty. This created clear, consistent points of contact for instrument needs, troubleshooting, and communication, while eliminating ambiguity and accelerating response times.
Nemours didn’t just stabilize staffing, but it eliminated vacancies entirely through a deliberate pipeline strategy, creating a sustainable model others can replicate.
With 100% certification and a structured clinical ladder, the department elevated SPD from a technical role to a true clinical profession tied to advancement and recognition.
From first-in-U.S. technology installations to techniciandriven workflow design, every investment was tied to resilience, quality, and efficiency, not just modernization.
The department removed flash sterilization entirely and replaced it with standardized, evidence-based workflows, reducing risk and improving consistency.
SPD is embedded in facility design, policy development, and system strategy, positioning it as a core driver of surgical performance, not a downstream function.

Daily huddles and cross-department collaboration reinforced that alignment. Leaders from both teams regularly spend time in each other’s environments, creating transparency and shared accountability around performance.
“Creating transparent, collaborative relationships between SPD, the OR, regulatory, and infection prevention teams is critical, reinforcing shared accountability,” Gilliam said.
To drive quality improvements, the organization established a multidisciplinary tray quality committee that meets daily to review issues in real time, identify trends, and implement corrective actions. This approach has enabled faster root cause analysis and continuous process refinement.
A data-driven focus on bioburden reduction further highlights this collaboration. By tracking “360 events,” which are instances where contamination completes the full reprocessing cycle undetected, the team has created a visible, measurable quality benchmark. The result is extended periods without events and a culture of rapid learning when issues occur.
Underpinning all of this is shared data. Transparent, trusted metrics
serve as a single source of truth, helping eliminate blame, align teams, and focus conversations on performance and improvement rather than perception.
Nemours isn’t just implementing best practices; it’s helping define them.
A department-led study evaluating extended endoscope hang time from seven to 14 days demonstrated zero failures over a 150-day trial.
The change has since been adopted as standard practice, increasing capacity while maintaining safety.
The findings have been presented at national conferences and published in peer-reviewed literature, extending the department’s influence beyond its own walls.
“Participation in research and knowledge sharing allows us to move beyond tradition and anecdote and toward evidence-based practice,” Gilliam noted.
This ability to translate operational challenges into research, and research into scalable solutions, is a hallmark of leading organizations.
Workforce Excellence
• 0% vacancy rate
• 0 travelers or agency staff
• 100% CRCST-certified team
• Advancing toward 75% CER certification
Clinical Reach & Scale
• Supports 12 operating rooms
• Covers two procedure rooms and one endoscopy suite
• Serves 13 clinics across 18 specialties
• Over 12,000 pediatric patients are supported annually
Workforce Pipeline & Training
• 400 hours of on-site training for externs
• Partnerships with Delaware Tech and community programs
• Participant in Health Anchor Network (HAN) workforce initiative
Technology & Innovation
• First U.S. installation: self-contained steamgeneration autoclave
• First U.S. installation: Torvan Safe Cleanbox (2025)
• Advanced fleet of Steris sterilizers, washers, and endoscope reprocessors
• Customized ergonomic workstations designed with technician input
Quality & Performance
• Zero failures in 150-day endoscope reprocessing study
• Transition from seven-day to 14-day endoscope hang time
• Elimination of flash sterilization for five-plus years







Better tools build better outcomes. Let’s strengthen endo together.
Endoscope processing is built on a series of critical steps, and each one calls for tools that support clarity and compliance. Our endo-focused solutions and educational support are designed to help your team build a strong foundation for success.
Manual Cleaning
Labeling
Protective Equipment
Inspection Tools
Transport & Storage
Educational Resources




Let’s build a stronger endo foundation for your team.
Scan to get started.
From crisis to high reliability: Model for SPD transformation
Children’s Hospital Colorado’s Sterile Processing Department stands out for one of the most significant transformation stories in this year’s field. Just a few years ago, the department faced a serious operational and regulatory crisis, culminating in an Immediate Jeopardy citation. Rather than pursuing short-term fixes, leadership used the moment as a catalyst for a comprehensive rebuild that was grounded in quality, accountability, and long-term sustainability.
Since 2025, the department has implemented a formal quality management program anchored by standardized work, visible performance metrics, and routine internal audits. This shi from reactive problem-solving to proactive quality assurance has improved accuracy, strengthened compliance, and rebuilt trust with perioperative partners. Workforce stabilization has been equally critical. Open positions have been dramatically reduced, reliance on agency labor has declined, and a structured onboarding and education program has created consistency across teams and campuses.
Technology has also played a key role in the department’s evolution. Integration between the electronic health record and sterile processing systems has enabled proactive case planning, improved instrument readiness, and enhanced traceability. At the same time, centralized inventory management and significant capital investment in instrumentation and infrastructure have reduced delays, minimized stockouts, and improved overall efficiency.
What distinguishes Children’s Hospital Colorado is not just recovery, but reinvention. The department has moved beyond compliance to become a high-reliability operation with a strong culture of engagement, accountability, and continuous improvement. Its journey offers a powerful blueprint for other health systems facing similar challenges.
From backlog to reliability: Rebuilding SPD for consistent surgical support
ChristianaCare’s Sterile Processing Department has undergone a significant operational turnaround, transforming from a system challenged by backlog and variability into a more stable, highreliability partner in surgical care. Supporting more than 21,000 surgical cases across multiple campuses, the department processes over 1,000 trays daily in a complex, high-acuity environment.
One of the most notable achievements has been the reduction of a substantial instrument backlog. Previously ranging between 500 and 900 trays, the backlog has been reduced to a manageable level, significantly improving start-of-day readiness and supporting on-time surgical case starts. This progress has been driven by a combination of workflow redesign, improved staffing alignment, and enhanced operational oversight.
Workforce stabilization has been another critical component of the department’s success. ChristianaCare eliminated reliance on contract labor and established an internal Sterile Processing Trainee Program to build a sustainable talent pipeline. Weekly training sessions, standardized competencies, and clear productivity expectations have strengthened both performance and accountability across the team.
The department has also advanced its approach to quality through detailed defect tracking and data transparency. By categorizing defects and analyzing trends by service line, the team can target improvements more effectively and engage perioperative partners in shared problem-solving. Cross-training initiatives and joint education efforts have further strengthened collaboration between sterile processing and the operating room.
Looking ahead, ChristianaCare is focused on expanding its use of technology, including enhanced system integration and evaluation of advanced inspection tools, to further reduce variation and improve reliability.
ChristianaCare’s journey demonstrates how disciplined execution, workforce investment, and data-driven decision-making can restore confidence in sterile processing and support consistent, high-quality surgical care.
Grady Health System’s Sterile Processing Department operates at the heart of one of the nation’s busiest Level I trauma centers, where speed, accuracy, and reliability are critical to patient outcomes. In this high-pressure environment, the department has built a culture defined by teamwork, accountability, and service excellence.
The team’s performance is reflected in strong, consistent metrics. Case cart accuracy rates approach 100%, on-time tray delivery exceeds 95%, and response times to the operating room average less than five minutes. These outcomes are supported by a highly trained workforce, with 95% of staff certified and 100% cross-trained across all functional areas. This flexibility allows the department to adapt quickly to fluctuating surgical demand, including urgent and emergent trauma cases.
A key driver of success has been the department’s emphasis on communication and collaboration. Daily huddles, OR liaison roles, and regular interdisciplinary meetings ensure alignment between sterile processing and perioperative teams. This structure enables rapid issue escalation, real-time problem-solving, and a shared commitment to patient safety.
Grady has also invested in continuous improvement through the adoption of advanced inspection technologies, standardized workflows, and a long-term capital planning strategy. These efforts
have resulted in reduced rework rates, improved throughput, and sustained regulatory readiness, including strong performance during accreditation surveys.
In an environment where there is li le margin for error, Grady Health System’s Sterile Processing Department exemplifies how disciplined processes and a cohesive team can deliver reliable performance under constant pressure.
Scaling sterile processing for one of the nation’s most complex surgical environments
At NYU Langone Health, sterile processing operates at a scale and level of complexity few organizations can match. Supporting 71 operating rooms and procedural areas across its Manha an campus, the department processes approximately 23,000 instrument sets each month while accommodating rapid growth in high-acuity specialties such as transplant, robotics, and neurosurgery.
To manage this complexity, NYU Langone has built a highly structured, data-driven operation grounded in Lean and Six Sigma principles. Over the past several years, the department has achieved measurable improvements across key performance areas. Defect rates have fallen below 1%, missing instrument spend has been reduced by more than 60%, and case cart preparation times have been cut in half. These gains have been realized while continuing to support increasing procedural volume, demonstrating the department’s ability to scale without compromising quality.
Central to this success is a strong focus on analytics and accountability. Enterprise dashboards track performance across quality, productivity, and service metrics, enabling leaders to identify trends, address variation, and drive continuous improvement. Dedicated roles, including OR liaisons and instrument coordinators, further strengthen alignment with perioperative teams and ensure consistent case readiness.
Beyond operational performance, NYU Langone has invested in workforce development through structured education programs, leadership training, and formal preceptor initiatives. These efforts support both frontline staff and emerging leaders, helping sustain performance in a demanding, high-volume environment.
NYU Langone’s sterile processing operation demonstrates how large academic medical centers can combine scale, precision, and innovation to deliver consistent, high-quality surgical support.

Perhaps the most important shift at Nemours is how sterile processing is positioned within the organization. SPD leaders are actively involved in facility design, workflow planning, and systemwide policy development, including enterprise standards for humidity control and sterile storage.
They are contributing to new surgical center builds, influencing equipment selection, and shaping operational strategy across multiple sites. In short, SPD is no longer operating behind the scenes, but it is embedded in decision-making at every level.
“SPD should be viewed as a core clinical service,” Gilliam added. “One that plays a critical role in infection prevention, regulatory readiness, fiscal stewardship, and patient outcomes.”
Nemours offers a clear counterpoint to many of the challenges facing sterile processing today.
While others struggle with staffing gaps, inconsistent training, and reactive operations, Nemours demonstrates what’s possible with a proactive, systemwide approach:
• Workforce pipelines instead of short-term hiring fixes.
• Certification-driven professionalism instead of baseline competency.
• Technology investments tied to resilience, not just replacement.
• Research and data guiding operational decisions.
• SPD integrated as a strategic partner across perioperative services.
The result is not just a high-performing department; it’s a model for what the future of sterile processing can look like. HPN
BY ADAM OKADA
Q: “At our facility, we require sterile processing technicians to be certified within one year of employment, but there is no certification requirement for those who are reprocessing flexible scopes. Shouldn’t they also have a certification requirement?”
A: You make an excellent point, and one that our industry tried to address with the most recent version of ANSI/ AAMI ST91:2021 1
In ST91 Section 6.31 – Education, training, and competency verification, it states, “All personnel performing endoscope processing shall complete formal training and competency verification in all aspects of endoscope processing prior to first assignment to perform these tasks independently. All personnel performing processing of endoscopes should be certified in flexible endoscope processing within two years of employment and should maintain that certification throughout their employment.”


are striving for best practice should be following them. Which, shouldn’t we all?
A. Standards
There are two parts to this statement that are important to break down. Let’s first talk about the standards themselves, the language used, and the difference between should and shall
The Association for the Advancement of Medical Instrumentation (AAMI) documents are consensus best practice standards. While hospitals should have them on hand and know what they say, there is no legal requirement for hospitals to follow them. For example, surveyors will not cite a facility for not following these standards unless the facility has them listed in their policies and/ or procedures or the facility staff tells the survey team that they are following AAMI standards. This is in contrast to legal requirements from the city/county/state level and regulations like Occupational Safety and Health Administration (OSHA) with the OSHA Bloodborne Pathogens Standard,2 which must be followed by all healthcare facilities.
However, consensus standard documents are best practice standards for our industry, and hospitals that
Is your facility following AAMI or any other standards (i.e., AORN, SGNA, etc.) recommendations? If they are cited in your policies, procedures, or training documents (like competencies), then surveyors will use them to ensure you comply with certain statements in the standard.
B. Shall and Should
1. The “shall” statements are the most important to follow, as they are requirements of the standard. Recalling ST91 Section 6.31 above, “All personnel performing endoscope processing shall complete formal training and competency verification in all aspects of endoscope processing prior to first assignment to perform these tasks independently.”
• This means it is a requirement if you are following AAMI ST911 standards.
• Basically, anyone who is responsible for processing flexible endoscopes, whether a dedicated processing technician or the tech in the patient room, is required to have competency training prior to working on their own.
2. The “should ” statement stops short of this being a requirement of AAMI and falls into the next most important category. It applies to certification. “All personnel
performing processing of endoscopes should be certified in flexible endoscope processing within two (2) years of employment and should maintain that certification throughout their employment.”
• “Should” statements are recommendations, and your facility should have a justifiable reason if they are not following them.
•The standard strongly recommends that processing personnel should be certified.
The reason behind this updated recommendation is simple. We want highly skilled and well-trained individuals to process our most complex devices, like flexible endoscopes.
There are some specialized studies that support the recommendation of ST91 Section 6.3.1
A 2025 study by Cori Ofstead & Associates3 highlights how prevalent processing breaches or missed steps in the process are. I recommend reviewing this particular study, as it demonstrates how pervasive deficiencies are across all areas of sterile processing.
A collaborative study published by the Centers for Disease Control and Prevention (CDC) in 20204 found that even when all processing steps were followed, there was still biological material found on processed endoscopes.
If you aren’t familiar with the U.S. Food and Drug Administration’s (FDA) Manufacturer and User Facility Device Experience (MAUDE) database,5 I strongly recommend exploring it. This database features thousands of adverse patient events caused by critical steps being overlooked during the cleaning/inspection process of flexible scopes or by damage to equipment before reaching any patients. We can learn from these missed opportunities in the profession.
I don’t cite these studies or point to the adverse patient outcomes to scare you. But the need is clear: a competent, well-trained individual is the best hope to avoid these tragic outcomes. This is where certification comes in.
The definition of certification is when a professional organization validates that an individual has met specific, predetermined standards of knowledge, skill, and experience in a specialty area. This can usually be accomplished through a combination of real-world experience (often a 400-hour or 3-month hands-on experience requirement) and a competency exam.
Certification shows the professionalism of the processing technician. It shows the individual cares enough about the subject to pay, study, and sit for a competency exam. Each certification has a tremendous amount of information in their manuals, and it’s no easy feat to pass their accompanying exams. I would strongly recommend a course that can help distill the information and apply it to real-world processing. Just be careful of scams and exorbitant pricing on some of them!
While the exam process and book knowledge are important, perhaps the more important part of the certification process is to understand the risks associated with complex devices like flexible scopes and the importance of following instructions for use (IFU) and best practice standards. When someone is simply trained on the handson “nuts and bolts” of processing steps, there isn’t a clear correlation to the infection risks associated with skipping them. All the current certification methods make it clear that following the manufacturers’ IFU is of particular importance, and they do a great job of showing the “why” behind each of the processing steps. For instance, “Why is it important to leak test your scope?” might seem like an unnecessary step to those who have never learned about the “why,” but when you learn about the risks associated with fluid invasion, the importance of this step really hits home.
As for the certifications themselves, I have heard pros and cons with each, but both are excellent options. The Healthcare Sterile Processing Association’s (HSPA) CER6 is the most popular among them, but the Certification Board for Sterile Processing and Distribution (CBSPD) offers CFER,7 which is an excellent program as well. Endoscopy departments will likely hire certified technicians with either certification. (Note: I haven’t yet heard of a department that requires one over the other.) It’s up to the individual to examine each method and determine which will work best for them.
Certification is vital to patient health because it means that well-educated individuals are processing the scopes that will be used on them. Always remember that a patient undergoing a procedure is at their most vulnerable and cannot defend themselves against infections resulting from poor processing practices. Patients rely on sterile processing technicians who are properly educated, trained, and diligent in the steps of processing for every patient, every time. HPN
1. Association for the Advancement of Medical Instrumentation. (2021). ANSI/AAMI ST91:2021 Flexible and semi-rigid endoscope processing in health care facilities (Section 6.3—Education, training, and competency verification).
2. Occupational Safety and Health Administration. (2020). Occupational exposure to bloodborne pathogens (29 CFR 1910.1030). U.S. Department of Labor. https://www.osha.gov/laws-regs/ regulations/standardnumber/1910/1910.1030
3.Ofstead, C. L., Smart, A. G., Hurst, L. L., Lamb, L. A. (2025, July). Endoscope processing effectiveness: A reality check and call to action for infection preventionists and clinicians. American Journal of Infection Control, 53(7), 785 793. https://doi.org/10.1016/j.ajic.2025.04.003
4. Benowitz, I., Beer, K. D., & Gierke, R. (2020). Gastrointestinal flexible endoscopes: Infection control risks, lessons learned from outbreaks, and Centers for Disease Control and Prevention guidance. Centers for Disease Control and Prevention. https://stacks.cdc.gov/view/cdc/104184
5.U.S. Food and Drug Administration. (n.d.) MAUDE - Manufacturer and User Facility Device Experience. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
6. Healthcare Sterile Processing Association. (n.d.). Certified endoscope reprocessor (CER). https://myhspa.org/certification/certification-overview/certified-endoscope-peprocessor-cer/ 7.Certification Board for Sterile Processing and Distribution. (n.d.). Certified flexible endoscope reprocessor (GI SCOPE). https://www.cbspd.net/gi-scope/
BY SARAH B. CRUZ
In sterile processing (SP), standards are not academic references. They exist to control risk, guide decisions, and protect patients when processes are stressed, questioned, or challenged. Among them, the Association for the Advancement of Medical Instrumentation Standard ST79 remains the most influential document governing steam sterilization practices. It shapes how SP departments design workflows, validate equipment, configure loads, monitor cycles, store products, and determine whether an item is safe to release for patient use.
1. Explain how ST79 functions as a riskcontrol and decisionmaking tool in Sterile Processing operations.
2.Recognize barriers and oversights that limit effective use of ST79 in daily practice.
3. Implement strategies to integrate ST79 into education, SOPs, and perioperative collaboration.
Sponsored by:

Yet in many facilities, ST79 continues to function primarily as a defensive document. It is pulled during surveys, cited after findings, and referenced when something goes wrong. When standards are used this way, they lose their value as operational tools. Practice becomes habit-driven, policy drifts away from reality, and risk accumulates quietly until it is exposed under pressure.
Effective education reframes ST79 as a risk-control and decision-making tool, not a survey weapon. When applied intentionally, it reframes standards as operational protection. It elevates SP from compliance support to clinical partner and gives educators and leaders permission to teach standards proactively, not apologetically.
Most facilities introduce ST79 in predictable ways. New technicians receive an overview during orientation. Annual competencies reference selected requirements. Educators incorporate language from the standard when updating policies or preparing for accreditation. Vendor education may supplement training when new sterilizers or accessories are introduced.
These efforts are not ineffective, but they are incomplete. ST79 is often taught as background knowledge rather than as an operational expectation. Education is delivered in large segments, disconnected from
•The standard guides decisions before outcomes are determined
•Practice changes are checked against requirements
•Variation prompts review, not acceptance
•Escalation is expectationbased, not role-based
•ST79 informs discussions outside of SP departments
the real decisions technicians make on the floor. Staff may know the standard exists but are not taught how to use it when parameters drift, loads fail, or workflow shortcuts present themselves.
As a result, practice is guided by routine rather than requirements. Escalation depends on who is present rather than what is expected. The standard exists, but it does not actively shape behavior.
Departments that integrate ST79 into daily operations look different. The standard is visible in decisionmaking, not hidden behind policy language. Policies align clearly with requirements. Leaders reference expectations when discussing equipment limitations, staffing needs, and workflow redesign.
In these environments, ST79 functions as infrastructure. It supports capital planning, validates staffing discussions, and provides clarity during process failures. Technicians are not expected to memorize clauses, but they understand the purpose behind requirements. They recognize when conditions no longer support safe sterilization and feel empowered to escalate concerns.
This is where ST79 stops being defensive and becomes operational. It strengthens professional judgment and reinforces the role of SP as a clinical partner invested in patient safety.
The most common failure in ST79 education is relevance. Standards are presented as rules to follow rather than safeguards designed to prevent harm. Technicians are told what to do without understanding why deviation matters.
Timing is another issue. Orientation and annual education alone cannot sustain effective practice in a department where conditions change daily. Equipment ages, case mix evolves, and workload fluctuates. Education that does not keep pace with reality loses credibility.
There is also reluctance to challenge long-standing practices. When requirements conflict with how work has always been done, education becomes uncomfortable. Without leadership support, these gaps remain unaddressed, and risk persists.
Production pressure is real. SP departments are measured by output, and education is often deprioritized. When time is limited, standard education becomes reactive.
Ownership also matters. When ST79 is framed as something leadership uses during surveys, technicians disengage. The standard feels punitive rather than protective.
Finally, ST79 is comprehensive and written for a broad audience. Without interpretation and translation into workflow-specific expectations, it can feel inaccessible. Distribution alone does not drive application.
One of the most damaging oversights is using ST79 only after something goes wrong. When the standard appears only in response to failure, staff associate it with blame rather than prevention.
Another oversight is failing to link ST79 directly to standard operating procedures (SOPs). Policies may cite the standard, but technicians are rarely shown how requirements connect to their tasks. This weakens consistency and accountability.
Facilities also frequently fail to define clear stop-and-escalate expectations. Technicians may recognize unsafe conditions but lack explicit authority to pause a process. Without defined escalation pathways, deviation becomes normalized.
Turning ST79 into a living standard requires integration. Requirements must be embedded into SOPs, work instructions, and competency assessments. When staff see how expectations map directly to their work, compliance becomes intentional. Education should follow workflow, not chapter order. Teaching requirements in the context of decontamination, assembly, sterilization, and storage allows immediate application. Short, focused learning tied to real scenarios is more effective than broad overviews. Clear escalation criteria are essential. Technicians must know when to stop, what constitutes deviation, and who to notify. This removes ambiguity and protects patients. Leadership behavior reinforces this shift. Referencing ST79 during daily

This lesson was developed by Solventum. Lessons are administered by Endeavor Business Media.
A er careful study of the lesson, complete the examination online at educationhub.hpnonline.com. You must have a passing score of 80% or higher to receive a certificate of completion.
The Certification Board for Sterile Processing and Distribution has preapproved this in-service unit for one (1) contact hour for a period of five (5) years from the date of original publication. Successful completion of the lesson and post-test must be documented by facility management and those records maintained by the individual until recertification is required. DO NOT SEND LESSON OR TEST TO CBSPD. www.cbspd.net


Association, myhspa.org, has pre-approved this in-service for 1.0 Continuing Education Credits for a period of three years, until March 31, 2028.
For more information, direct any questions to Healthcare Purchasing News editor@hpnonline.com.

discussions signals that the standard is an operational expectation. It gives educators permission to teach standards proactively, not apologetically.
Although often labeled an SP department standard, ST79 affects the entire perioperative environment. Operating room practices influence contamination risk. Case scheduling affects sterilizer capacity. Instrument handling decisions shape reprocessing outcomes. SP professionals are positioned to lead these conversations. Joint education with perioperative partners clarifies shared responsibility and reduces friction. Using ST79 as a common reference shifts discussions from opinion to evidence and strengthens collaboration.
A sustainable ST79 education model requires consistency. Orientation alone is not enough. Annual education alone is not enough. The standard must be reinforced through daily practice, competency validation, and performance improvement. Success is evident when technicians
can explain why requirements exist, identify risk when practice deviates, and escalate appropriately. When that happens, ST79 stops being something departments point to and starts being something they practice.
ST79 was not written to sit idle until it is needed for defense. It was written to guide practice, control risk, and support sound decision-making before outcomes are questioned. When it is treated only as a compliance reference, its value is limited and its intent is lost.
Teaching ST79 as an operational standard restores its intent. It reframes standards as protection. It strengthens professional judgment, clarifies when and how to escalate concerns, and aligns policy with real-world practice. Most importantly, it elevates SP from a compliance support role to a clinical partner within perioperative services. When ST79 is embedded into daily work, it becomes more than a document. It becomes a tool that actively shapes behavior and protects patients. HPN
1.ST79 is intended to guide safe sterilization practice and risk control, not solely to support survey or audit responses.
☐ True ☐ False
2.Which approach best supports effective use of ST79 in Sterile Processing?
A.Memorizing clauses
B.Applying requirements within real workflows
C.Reviewing annually only
D.Limiting access to leadership
3.Should ST79 be considered during planning for workflow changes or equipment selection?
☐ True ☐ False
4.Using ST79 operationally helps elevate Sterile Processing from compliance support to clinical partner.
☐ True ☐ False
5.Which factor commonly limits effective ST79 education?
A.Lack of standards
B.Time pressure and production demands
C.Excessive oversight
D.Over-training
All CEU quizzes must be taken online at: educationhub.hpnonline.com The cost to take the quiz is $10.
6.Should escalation decisions be driven primarily by job title or hierarchy?
☐ True ☐ False
7.Which action best supports making ST79 operational?
A.Keeping it for surveys
B.Using it only after failures
C.Embedding it into SOPs and competencies
D.Assigning it to leadership only
8.Using ST79 only after problems occur can associate the standard with blame rather than prevention.
☐ True ☐ False
9.Why should ST79 inform discussions beyond Sterile Processing?
A.To reduce policies
B.To meet documentation needs
C.Because perioperative practices affect outcomes
D.Because it applies only to leaders
10.Are orientation and annual education alone sufficient to sustain effective ST79 use?
☐ True ☐ False


'5<,1*,6127$1 237,21 ,7·6(66(17,$/
+o m;;71om=b7;m1;0;=ou;v|;ubѴb -|bom "|;ubѴ;ruo1;vvbm]7;r-u|l;m|v=-1; bm1u;-vbm]1_-ѴѴ;m];v _;m7u bm]1olrѴ; Ѵ l;m;7bmv|u l;m|v !;vb7 -Ѵlobv| u;1-m
1olruolbv;v|;ubѴb -|bom-m77;Ѵouh=Ѵo $_; ƑƏƏ l;m u bm]
" v|;lŖ7;Ѵb ;uv1om|uoѴѴ;7-bu=Ѵo 7;vb]m;7 |o;mv u;1Ѵbmb1-ѴѴ 7u Ѵ l;mvrubou|o v|;ubѴb -|bom
$! &)ş!(
ƑƏƏ& !+"+"$

;vb]m;7=ou|o7- Ľvlov|1olrѴ; uo0o|b1v u]b1-Ѵbmv|u l;m|v mv u;v1Ѵbmb1-ѴѴ 7u Ѵ l;mv0;=ou;v|;ubѴb -|bombmƒƏlbm |;vouѴ;vv 11;Ѵ;u-|;v" ouh=Ѵo _bѴ;u;7 1bm]7u bm]0o||Ѵ;m;1hv
ol;v;; v-|"ƑƏƑѵĴoo|_Ųƕƒƒ












Save over 50 minutes per PAR location per day
Clinicians, simply pull down the Flipper when you access supplies from the back bin when the front bin is empty. That’s it!
Supply Techs manage supplies from the Intelli-Flip web based portal.
Fully automate your ordering process by integrating Intelli-Flip with your ERP system.
To learn more or to request a demo, go to Intelli-Flip.com.


